Trusted Resources: Education
Scientific literature and patient education texts
Parent Perceptions in Choosing Treatment for Infants With Spinal Muscular Atrophy Diagnosed Through Newborn Screening
source: Journal of Child Neurology
year: 2022
authors: Deng S, Lee BH, Ciafaloni E
summary/abstract:Objective: To identify factors parents considered in treatment decision making for children diagnosed with spinal muscular atrophy on newborn screening.
Methods: Participants were recruited through the University of Rochester or through flyers and Cure SMA social media outreach and asked to complete a telephone or online survey. Data were analyzed through mixed methods using descriptive statistics and theme identification in narrative responses.
Results: Eighteen parents with children diagnosed with spinal muscular atrophy on newborn screening participated. Thirteen of 18 chose onasemnogene abeparvovec, 2 of 18 chose risdiplam, 1 of 18 chose nusinersen, and 2 of 18 did not receive treatment. The most commonly reported factors impacting treatment choice included treatment frequency and administration method. Seventeen (94.4%) parents felt that inclusion of spinal muscular atrophy on newborn screening was positive because it could allow for better outcomes with earlier treatment.
Conclusion: Treatment frequency and administration method were the most important factors for parents in determining spinal muscular atrophy treatment. Parents felt positively about newborn screening due to opportunity for earlier treatment.
organization: University of Rochester, USADOI: 10.1177/08830738211040292
read more
Related Content
-
Measuring the SMA Experience: Laura’s Storyhttps://www.youtube.com/watch?v=LNpcXiiW...
-
The Antisense Oligonucleotide Nusinersen for Treatment of Spinal Muscular AtrophySpinal muscular atrophy (SMA) is a rare,...
-
SMA FoundationThe mission of the SMA Foundation is to ...
-
Equipment Donations at SMA ClinicThe Pediatric SMA Clinical Research Cent...
-
Patient of the Month: GiannaAfter noticing that her daughter was una...
-
Despite Taking Spinraza, SMA Type 1 Children Show Nonmotor ProblemsDespite its well-reported benefits in mo...
-
A Dallas Startup Aims to Build a Big Business—and Transform Lives—by Curing Rare DiseasesBabies born with spinal muscular atrophy...